* Acutus Medical Inc AFIB.OQ reported a quarterly adjusted
loss
of 63 cents per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 64 cents per share.
* Revenue rose 29.8% to $5.29 million from a year ago;
analysts
expected $4.53 million.
* Acutus Medical Inc's reported EPS for the quarter was a
loss
of 63 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Acutus Medical Inc shares had fallen by 22.3% this
quarter and
lost 40.0% so far this year.
* The company reported a quarterly loss of $18.35 million.
* Wall Street's median 12-month price target for Acutus
Medical
Inc is $1.75
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 7 at 10:01 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.64 -0.63 Beat
Mar. 31 2023 -0.69 -0.57 Beat
Dec. 31 2022 -0.71 0.41 Beat
Sep. 30 2022 -0.81 -0.72 Beat